Markets.com Logo

BIIB

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    3245.5399$
  • Previous Close
    3245.5399$
  • 52 Week Change
    961.00$
  • Day Range
    0.00$
  • 52 Week High/Low
    2395$ - 3356$
  • Dividend Per Share
    --
  • Market cap
    487 789 M$
  • EPS
    --
  • Beta
    0.145
  • Volume
    --

About

The financial product symbol BIIB.MX refers to Biogen Inc. shares traded on the Mexican Stock Exchange (Bolsa Mexicana de Valores). It represents a share of ownership in Biogen Inc., a biotechnology company, but specifically when bought or sold through the Mexican market. Investors in Mexico use this symbol to trade Biogen shares locally.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

BIIB.MX is likely a ticker representing Biogen Idec stocks traded on the Mexican stock exchange. Factors affecting its price are similar to those impacting Biogen shares globally. Drug Development & Clinical Trial Results: Positive trial outcomes for Biogen's drugs, especially in areas like Alzheimer's or multiple sclerosis, often boost the stock price. Conversely, negative results or trial failures can lead to significant price drops. Regulatory Decisions: FDA approvals or rejections of Biogen's therapies directly influence investor confidence. Approval means revenue potential, while rejection can severely hamper growth prospects. Competition: New competitive drugs entering the market can erode Biogen's market share and profitability, affecting the stock price. Market Sentiment: Overall market conditions and investor confidence in the biotech sector play a role. Bull markets tend to lift most stocks, while bear markets can pull them down. Company Financial Performance: Biogen's earnings reports, revenue growth, and profit margins are scrutinized by investors. Strong financials can attract buyers, while weak performance may lead to selling pressure. Patent Expirations: When patents on key Biogen drugs expire, generic competitors can enter the market, reducing Biogen's revenue stream and potentially lowering the stock price. Mergers and Acquisitions: Rumors or announcements of potential mergers, acquisitions, or licensing deals can significantly impact the stock price. Economic Conditions: Broader economic factors, such as inflation, interest rates, and economic growth, can indirectly affect Biogen's stock price. Analyst Ratings: Recommendations from financial analysts can influence investor perception of Biogen's stock. Upgrades often lead to price increases, while downgrades can cause declines.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--